Skip to main content
. 2017 Apr 28;96(17):e6782. doi: 10.1097/MD.0000000000006782

Figure 5.

Figure 5

Map (Pentacam) showing the difference of corneal refractive power (RP) of an example eye in Group 1. Three months after the twice-daily application of Timolol (during treatment), the RP in the central cornea decreased (left), compared to its pretreatment level (center), 1.4 D difference of RP was observed in the central cornea (right).